Mechanism of Action | Antiviral | % Correct |
---|---|---|
DNA Chain Teminators | Acyclovir | 75%
|
NNRTIs | Efavirenz | 75%
|
NRTIs | Zidovudine | 75%
|
NRTIs | Didanosine | 50%
|
NRTIs | Emtricitabine | 50%
|
Entry Inhibitors | Enfuvirtide | 50%
|
DNA Chain Teminators | Foscarnet | 50%
|
DNA Chain Teminators | Ganciclovir | 50%
|
DNA Chain Teminators | Valacyclovir | 50%
|
NRTIs | Abacavir | 25%
|
NRTIs | Adefovir | 25%
|
Adamantanes | Amantadine | 25%
|
Protease Inhibitors (HIV) | Atazanavir | 25%
|
INSTIs | Cabotegravir | 25%
|
DNA Chain Teminators | Cidofovir | 25%
|
PK Enhancers | Cobicistat | 25%
|
Protease Inhibitors (HIV) | Darunavir | 25%
|
INSTIs | Dolutegravir | 25%
|
NNRTIs | Doravirine | 25%
|
Protease Inhibitors (HIV) | Indinavir | 25%
|
NRTIs | Lamivudine | 25%
|
Protease Inhibitors (HIV) | Lopinavir | 25%
|
NNRTIs | Nevirapine | 25%
|
Neuramidase inhibitors | Oseltamivir | 25%
|
INSTIs | Raltegravir | 25%
|
NNRTIs | Rilpivirine | 25%
|
PK Enhancers | Ritonavir | 25%
|
Protease Inhibitors (HIV) | Ritonavir | 25%
|
DNA Chain Teminators | Valganciclovir | 25%
|
Endonuclease Inhibitor | Baloxavir marboxil | 0%
|
INSTIs | Bictegarvil | 0%
|
Protease Inhibitors (HCV) | Bocepravir | 0%
|
DNA Chain Teminators | Brincidofovir | 0%
|
NS5As | Daclatasvir | 0%
|
NS5Bs | Dasabuvir | 0%
|
NNRTIs | Delaviridine | 0%
|
NS5As | Elbasvir | 0%
|
INSTIs | Elvitegravir | 0%
|
NRTIs | Entecavir | 0%
|
NNRTIs | Etraviridine | 0%
|
DNA Chain Teminators | Famciclovir | 0%
|
Protease Inhibitors (HIV) | Fosamprenavir | 0%
|
Entry Inhibitors | Fostemsavir | 0%
|
Protease Inhibitors (HCV) | Glecaprevir | 0%
|
Protease Inhibitors (HCV) | Grazoprevir | 0%
|
Others | Imiquimod | 0%
|
Others | Interferon | 0%
|
NS5As | Ledipasvir | 0%
|
Others | Letermovir | 0%
|
Entry Inhibitors | Maraviroc | 0%
|
NS5As | Ombitazvir | 0%
|
Entry Inhibitors | Palivizumab | 0%
|
Protease Inhibitors (HCV) | Paritaprevir | 0%
|
Others | Peginterferon | 0%
|
DNA Chain Teminators | Penciclovir | 0%
|
Neuramidase inhibitors | Peramavir | 0%
|
NS5As | Pibrentasvir | 0%
|
Viral Polymerase Inhibitor | Remdesivir | 0%
|
Others | Ribavirin | 0%
|
Adamantanes | Rimantadine | 0%
|
Protease Inhibitors (HCV) | Simeprevir | 0%
|
NS5Bs | Sofsbuvir | 0%
|
NRTIs | Stavudine | 0%
|
Others | Tecovirimet | 0%
|
Protease Inhibitors (HCV) | Telapravir | 0%
|
NRTIs | Tenofovir alafenamide|TAF | 0%
|
NRTIs | Tenofovir disoproxil fumarate|TDF | 0%
|
NS5As | Velpatasvir | 0%
|
Protease Inhibitors (HCV) | Voxilaprevir | 0%
|
Neuramidase inhibitors | Zanamavir | 0%
|
Copyright H Brothers Inc, 2008–2024
Contact Us | Go To Top | View Mobile Site